Late-Course Adjuvant Radiotherapy Concurrent with CDK4/6 Inhibitor for High-risk Breast Cancer: A Single -Center Randomized Controlled Trial Study
Clinical Breast Cancer · 2026-11
DOI: 10.1016/j.clbc.2026.10.017 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Breast Cancer, 2026-11. Verfasst von Yang Hui und 4 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Guangxi Zhuang Region Health and Family Planning Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Guangxi Zhuang Region Health and Family Planning Commission
Zitieren
APA
Hui, Y., Yanxian, Z., Nana, T., Yanqing, Z., & Ying, L. (2026). Late-Course Adjuvant Radiotherapy Concurrent with CDK4/6 Inhibitor for High-risk Breast Cancer: A Single -Center Randomized Controlled Trial Study. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2026.10.017
Vancouver
Hui Y, Yanxian Z, Nana T, Yanqing Z, Ying L. Late-Course Adjuvant Radiotherapy Concurrent with CDK4/6 Inhibitor for High-risk Breast Cancer: A Single -Center Randomized Controlled Trial Study. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2026.10.017
BibTeX
@article{Hui2026,
author = {Hui, Yang and Yanxian, Zhang and Nana, Tao and Yanqing, Zhu and Ying, Lu},
title = {Late-Course Adjuvant Radiotherapy Concurrent with CDK4/6 Inhibitor for High-risk Breast Cancer: A Single -Center Randomized Controlled Trial Study},
journal = {Clinical Breast Cancer},
year = {2026},
doi = {10.1016/j.clbc.2026.10.017}
}
EUVIMED